- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT03232814
Walk on: A Community-based Approach to Increase Physical Activity Among Men Treated for Colorectal Cancer
Walk on: A Community-based Approach to Promote Participation in Physical Activity Among Men Treated for Colorectal Cancer
In Canada, over 102,900 men are diagnosed with cancer each year. Of these, 81,000 are diagnosed with colorectal cancer and an estimated 65% are expected to survive the disease for at least 5 years. Men who have completed treatment for colorectal cancer face many adverse physical, cognitive, psychological, and social effects. The Wellness Beyond Cancer Program at The Ottawa Hospital is a cancer survivorship program that helps people who have completed treatment for cancer, including men diagnosed with colorectal cancer, manage these effects. The Wellness Beyond Cancer Program does this through education and referral to supportive care services and programs offered throughout the city of Ottawa.
Group-based physical activity programs are one of the varied services and programs available to adults diagnosed with cancer in Ottawa. Such programs are offered through the Ottawa Regional Cancer Foundation (http://www.ottawacancer.ca) and Breast Cancer Action Ottawa (http://bcaott.ca). Research on these programs show that group-based physical activity can improve disease and treatment-related effects while promoting overall quality of life amongst women with cancer. However, few of these programs have targeted men, even though their needs and preferences have been shown to be very different from women. While men diagnosed with colorectal cancer might also benefit from group-based physical activity programs offered in the community, it is not known if such programs would effectively reach them and what the impact would be on their quality of life after cancer treatment.
It is believed that a men's group-based walking program could be an effective way to reach men and promote quality of life after cancer treatment. Therefore, a sustainable 8-week group-based walking program was developed. This project will seek to explore the feasibility and potential benefits of the program among men who have completed treatment for colorectal cancer and who are referred to the program from staff at the Wellness Beyond Cancer Program in a prospective single-arm trial.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Studietype
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Ontario
-
Ottawa, Ontario, Canada, K1N 6N5
- University of Ottawa
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Men 18 years of age or older;
- Have completed treatment for colorectal cancer <1 year;
- Willing to provide informed consent to participate in this study and willing to follow the study protocol;
- Have the ability to walk without the use of an assistive device (including a cane) or the help of another person;
- Able to read and understand English;
- Medically cleared to participate in the walking program as determined by their referring Wellness Beyond Cancer Program healthcare provider.
Exclusion Criteria:
- Congestive heart failure, clinically significant aortic stenosis, history of cardiac arrest, use of a cardiac defibrillator, uncontrolled angina, uncontrolled arrhythmia, myocardial infarction, major heart surgery, stroke, or pulmonary embolus;
- Uncontrolled hypertension (systolic blood pressure>200 mm Hg and/or diastolic blood pressure >110 mm Hg);
- The use of supplemental oxygen;
- Severe arthritis (i.e., osteoarthritis or rheumatoid arthritis);
- History of chest pain or severe shortness of breath either at rest or when engaging in physical activity;
- Hip fracture, hip or knee replacement in the past 6 months;
- Currently enrolled in another study involving a physical activity intervention.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ondersteunende zorg
- Toewijzing: NVT
- Interventioneel model: Opdracht voor een enkele groep
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Group-based walking
Participants will engage in one supervised outdoor group-based walking session per week for the 8 week program.
|
The walking prescription will be progressive in nature.
The program will begin with participants walking for approximately 20 minutes in weeks 1-3.
This will gradually increase to approximately 30 minutes in weeks 4-6.
Finally, this will increase to 45-60 minutes in weeks 7-8.
The program will promote walking at a moderate intensity as assessed by Borg's Rating of Perceived Exertion scale.
Each session will be preceded by a brief warm-up and followed by a brief cool-down period.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Recruitment rates
Tijdsspanne: Through study completion, an average of 8 weeks
|
The number of men who enrol in the study out of the number who are referred.
|
Through study completion, an average of 8 weeks
|
|
Retention rates
Tijdsspanne: Through study completion, an average of 8 weeks
|
The number of men who complete the intervention and all scheduled assessments.
|
Through study completion, an average of 8 weeks
|
|
Adherence rates
Tijdsspanne: Through study completion, an average of 8 weeks
|
The number of walking sessions men engage in out of the total recommended as part of the intervention.
|
Through study completion, an average of 8 weeks
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in Physical Activity Behaviour: Leisure Time Exercise Questionnaire (Godin & Shephard, 1985)
Tijdsspanne: Baseline (week 0) and post-intervention (week 8)
|
Change in participants' self-reported physical activity (over the past 7 days) from baseline to post-intervention.
|
Baseline (week 0) and post-intervention (week 8)
|
|
Change in Quality of Life: Functional Assessment of Cancer Therapy (FACT)-Colorectal (Ward et al., 1999; Yost et al. 2005)
Tijdsspanne: Baseline (week 0) and post-intervention (week 8)
|
Change in participants' self-reported quality of life from baseline to post-intervention.
|
Baseline (week 0) and post-intervention (week 8)
|
|
Change in Cognitive Functioning: FACT-Cognitive Function (Wagner et al., 2004)
Tijdsspanne: Baseline (week 0) and post-intervention (week 8)
|
Change in participants' self-reported cognitive functioning from baseline to post-intervention.
|
Baseline (week 0) and post-intervention (week 8)
|
|
Change in Affect: Positive and Negative Affect Schedule (Watson et al., 1988)
Tijdsspanne: Baseline (week 0) and post-intervention (week 8)
|
Change in participants' self-reported affect from baseline to post-intervention.
|
Baseline (week 0) and post-intervention (week 8)
|
|
Change in Depression: Center for Epidemiologic Studies Depression Scale 10-item Revised (Eaton et al., 2004; Radloff, 1977)
Tijdsspanne: Baseline (week 0) and post-intervention (week 8)
|
Change in participants' self-reported depressive symptoms from baseline to post-intervention.
|
Baseline (week 0) and post-intervention (week 8)
|
|
Change in Social Support: Relatedness to Others in Physical Activity Scale (Wilson & Bengoechea, 2010)
Tijdsspanne: Baseline (week 0) and post-intervention (week 8)
|
Change in participants' self-reported perceptions of social support from baseline to post-intervention.
|
Baseline (week 0) and post-intervention (week 8)
|
|
Change in Physical Self-Perceptions: Physical Self Description Questionnaire Short-Form (Marsh et al., 2010)
Tijdsspanne: Baseline (week 0) and post-intervention (week 8)
|
Change in participants' self-reported physical competence, confidence, and self-esteem from baseline to post-intervention.
|
Baseline (week 0) and post-intervention (week 8)
|
|
Change in Stress: Perceived Stress Scale (Cohen et al., 1982)
Tijdsspanne: Baseline (week 0) and post-intervention (week 8)
|
Change in participants' self-reported perceptions of stress from baseline to post-intervention.
|
Baseline (week 0) and post-intervention (week 8)
|
|
Change in Fatigue: Functional Assessment of Chronic Illness Therapy-Fatigue Scale (Yellen et al., 1997)
Tijdsspanne: Baseline (week 0) and post-intervention (week 8)
|
Change in participants' self-reported perceptions of fatigue from baseline to post-intervention.
|
Baseline (week 0) and post-intervention (week 8)
|
|
Participants' Overall Experiences: Qualitative Interviews
Tijdsspanne: Post-intervention (week 8)
|
Participants' perspectives on how the intervention contributed to their behavioural, physical, psychological and social functioning, as well as their overall quality of life.
|
Post-intervention (week 8)
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: Jennifer Brunet, PhD, University of Ottawa
Publicaties en nuttige links
Algemene publicaties
- Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983 Dec;24(4):385-96. No abstract available.
- Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988 Jun;54(6):1063-70. doi: 10.1037//0022-3514.54.6.1063.
- Godin G, Shephard RJ. A simple method to assess exercise behavior in the community. Can J Appl Sport Sci. 1985 Sep;10(3):141-6.
- Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage. 1997 Feb;13(2):63-74. doi: 10.1016/s0885-3924(96)00274-6.
- Marsh HW, Martin AJ, Jackson S. Introducing a short version of the physical self description questionnaire: new strategies, short-form evaluative criteria, and applications of factor analyses. J Sport Exerc Psychol. 2010 Aug;32(4):438-82. doi: 10.1123/jsep.32.4.438. Erratum In: J Sport Exerc Psychol. 2010 Dec;32(6):909-11.
- Ward WL, Hahn EA, Mo F, Hernandez L, Tulsky DS, Cella D. Reliability and validity of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) quality of life instrument. Qual Life Res. 1999 May;8(3):181-95. doi: 10.1023/a:1008821826499.
- Yost KJ, Cella D, Chawla A, Holmgren E, Eton DT, Ayanian JZ, West DW. Minimally important differences were estimated for the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) instrument using a combination of distribution- and anchor-based approaches. J Clin Epidemiol. 2005 Dec;58(12):1241-51. doi: 10.1016/j.jclinepi.2005.07.008. Epub 2005 Oct 13.
- Eaton WW, Muntaner C, Smith C, Tien A, Ybarra M. Center for Epidemiologic Studies Depression Scale: Review and revision (CESD and CESD-R), in The Use of Psychological Testing for Treatment Planning and Outcomes Assessment, M.E. Maruish, Editor. 2004, Lawrence Erlbaum: Mahwah, NJ. p. 363-377.
- Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Applied Psychological Measurement, 1977. 1: p. 385-401.
- Wagner L, Lai J-S, Cella D, Sweet J, Forrestal S. Chemotherapy-related cognitive deficits: development of the FACT-Cog instrument. Ann Behav Med, 2004. 27: p. S10.
- Wilson PM, Bengoechea EG. The relatedness to others in physical activity scale: evidence for structural and criterion validity. Journal of Applied Biobehavioral Research, 2010. 15(2): p. 61-87.
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Verwacht)
Studie voltooiing (Verwacht)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- WBCP:PA/CR
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Colorectale kanker
-
Sun Yat-sen UniversityNog niet aan het wervenCancer therapie-geïnduceerde trombocytopenie (CTIT)
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityActief, niet wervendPancreas Adenocarcinoom | Fase III Pancreaskanker American Joint Committee on Cancer v8 | Stadium 0 Pancreaskanker American Joint Committee on Cancer v8 | Stadium I alvleesklierkanker American Joint Committee on Cancer v8 | Stadium IV alvleesklierkanker American Joint Committee on Cancer...Verenigde Staten
-
Centre Hospitalier Universitaire, AmiensVoltooidEnt Cancer ScreeningFrankrijk
-
Hitit UniversityErol Olcok Corum Training and Research HospitalVoltooidHysterectomie (MeSH nr: E04.950.300.399) | Had een hysterectomie ondergaan | Had Not Been Diagnosed With Cancer | Na hysterectomieTurkije (Türkiye)
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)VoltooidAdenocarcinoom van de dunne darm | Stadium III Adenocarcinoom van de dunne darm AJCC v8 | Stadium IIIA Adenocarcinoom van de dunne darm AJCC v8 | Stadium IIIB dunne darm adenocarcinoom AJCC v8 | Stadium IV Adenocarcinoom van de dunne darm AJCC v8 | Ampulla van Vater Adenocarcinoom | Stadium III... en andere voorwaardenVerenigde Staten
-
University of UtahNational Cancer Institute (NCI)VoltooidVermoeidheid | Sedentaire levensstijl | Gemetastaseerd prostaatcarcinoom | Stadium IV prostaatkanker AJCC (American Joint Committee on Cancer) v8 | Stadium IVA prostaatkanker AJCC (American Joint Committee on Cancer) v8 | Stadium IVB prostaatkanker AJCC (American Joint Committee on Cancer) v8Verenigde Staten
-
Xijing HospitalActief, niet wervendBorstkanker | Borstkanker (Triple Negative Breast Cancer (TNBC))China
-
Shanghai Henlius BiotechNog niet aan het wervenBorstkanker (Triple Negative Breast Cancer (TNBC))China
-
Shandong Cancer Hospital and InstituteWervingGeavanceerd ductaal adenocarcinoom van de alvleesklier | Cancer Anorexia-Cachexia SyndroomChina
-
Georgetown UniversityNational Cancer Institute (NCI); American Cancer Society, Inc.; Susan G. Komen...VoltooidBestudeer Chinese vrouwen die zich niet hebben gehouden aan de richtlijnen voor screening op mammografie van de American Cancer SocietyVerenigde Staten
Klinische onderzoeken op Group-based walking
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)VoltooidObesitas | Cardiovasculaire risicofactor | Diabetes Mellitus-risico
-
The Cleveland ClinicNational Institute on Minority Health and Health Disparities (NIMHD); National...WervingDepressie | Vermoeidheid | Ongerustheid | Mentale gezondheid | SarcoïdoseVerenigde Staten
-
Riphah International UniversityVoltooidCerebrale paresePakistan
-
University of Alabama at BirminghamVoltooidNeuropatische pijn | RuggenmergletselsVerenigde Staten
-
Je Bouge Pour Mon MoralUniversity Grenoble AlpsVoltooidDepressieve symptomenFrankrijk
-
Ottawa Heart Institute Research CorporationVoltooid
-
University Hospital, BonnVoltooidPAOD (perifere arteriële obstructieve ziekte)Duitsland
-
Grand Valley State UniversityVoltooidZiekte van ParkinsonVerenigde Staten